Clinical Trials
3 trialsNCT04621188 2025-09-24
Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Active not recruiting
NCT04111705 2025-04-01
ORAKLE
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Completed
NCT06378892 2024-04-23
ALK-PPL
Centro di Riferimento Oncologico - Aviano
Phase 2 Recruiting